Methodist Health System

Compiled by PlainTrial · August 8, 2026

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Methodist Health System sits in the top decile of US sponsors by registered trial count (#215 of 15,742 sponsors by registered trial count).

125 total trials 36 currently recruiting 73 completed later-stage tilt top decile by trial count

Methodist Health System: 125 sponsored US clinical trials, 36 recruiting.

Methodist Health System sponsors 125 registered US clinical trials on ClinicalTrials.gov, 36 of them currently recruiting, and 73 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is SBO - Small Bowel Obstruction, with 1 trials.

Methodist Health System ranks in the top decile of sponsors by registered trial count (#215 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 74/100

73 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

125 total, page 2 of 3

Methodist Health System

Top-decile sponsor footprint

Open and recent trials

Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice

The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents

Review of Breast Abscess Management

Establishing the Chaplain Role in a Primary Care Clinic Setting

Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Rib Fracture Cryoanalgesia

Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit

Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery

Diagnosis of Gestational Diabetes Based on a 50-gram Glucose Challenge

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

Decreasing On-Shift Stress With a Crisis Intervention Cart

Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

Physician-Nurse Dyad Rounding: A Collaborative Approach to Improve Unit-Level Metrics

Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients

A Review of External Ventricular Drain Placement at the Bedside Versus Operating Room

Improving Charge Nurse Conflict Resolution Communication Using Artificial Intelligence

Robotic Bariatric Database (RBD) Collaborative

Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections

Resuscitative Thoracotomy Practices

Performance Improvement: Does Mock Code Simulation Improve the Confidence Level of Newly Graduated Nurses?

Perceptions and Prevalence of Workplace Violence in Healthcare

Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

Evaluation of the Impact of Reduced Immunosuppression

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit

Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation

Evaluation of an Anti-Shivering Protocol Cardiac Arrest

Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Are Personal Smartphones Hurting Work-Life Balance for Nurse Managers?

Outcomes Using MARS for Patients With ALF

Impact of Obesity on Clinical Outcomes in Patients Receiving Acyclovir for HSV Encephalitis"

Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres

Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient

Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

To Vape or Not to Vape

Relationships Between Vitamin D and Orthopedic Trauma

CT Change Management in Trauma Patients

Blood Product Supply

Fetal Outcomes Among Pregnant Emergency General Surgery Patients

Personalized Health Planning--Shared Medical Appointments for Obesity

Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)

Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus

Time to Lose the Weight? Comparison of Weight-based and Non-weight-based Vasopressors for Septic Shock

Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis

The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients

Phase Distribution

Therapeutic Areas

Where Methodist Health System enrollment is open (later-stage tilt)

Methodist Health System: open-pipeline peers nationwide

Sponsors near 125 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related